CYTOPENIA
Clinical trials for CYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CYTOPENIA trials appear
Sign up with your email to follow new studies for CYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for low blood counts after CAR T-Cell therapy?
Disease control Recruiting nowThis study tests a drug called emapalumab to see if it can safely help people whose blood cell counts stay dangerously low after CAR T-cell therapy for certain lymphomas. About 32 adults who have already received standard CAR T-cell therapy will take part. The goal is to find out…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a cancer drug stop a blood disorder before it turns deadly?
Disease control Recruiting nowThis pilot study is for people with high-risk CCUS, a blood condition that can lead to cancer. Participants can choose to be watched or take an oral drug called Inqovi (decitabine/cedazuridine). The goal is to see if early treatment is feasible and safe. The study is small and ea…
Matched conditions: CYTOPENIA
Phase: EARLY_PHASE1 • Sponsor: Lachelle D. Weeks, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug aims to boost red blood cells in MDS patients
Disease control Recruiting nowThis study tests a drug called elritercept (KER-050) in 160 adults with a bone marrow condition called myelodysplastic syndromes (MDS) who have anemia. The main goals are to check the drug's safety and how well people tolerate different doses. Researchers will also see if it help…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug may boost recovery in kids with rare bone marrow failure
Disease control Recruiting nowThis study tests whether giving emapalumab early can help children with newly diagnosed severe aplastic anemia recover their blood cell counts within 6 weeks. About 35 children will receive the drug before standard treatments. The goal is to see if this approach improves treatmen…
Matched conditions: CYTOPENIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood test may end painful bone marrow biopsies for MDS patients
Diagnosis Recruiting nowThis study is testing a new blood test called PERIBLOOD-MDS that could diagnose a bone marrow disorder called MDS without needing a painful bone marrow biopsy. Researchers will compare results from the blood test with standard bone marrow exams in 1,500 adults with low blood coun…
Matched conditions: CYTOPENIA
Sponsor: Weizmann Institute of Science • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New study uses DNA tests to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study is looking at 2,000 people who have early warning signs of blood cancers or bone marrow failure. Researchers use a special genetic test (next generation sequencing) to find changes in cancer-related genes. The goal is to better understand who is at risk and to catch th…
Matched conditions: CYTOPENIA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC